Professor Peter K. Law and Dr. Danlin Min were invited to participate in the "Symposium on Myoblast Treatment Technology"

 2017/03/27

On the morning of March 25, 2017, the "Symposium on Myoblast Treatment Technology" was held in the 1st conference room of the Eastern Hospital of Zhengzhou Children's Hospital. Prof. Peter K. Law and Dr. Danlin Min, Chairman of the board and Vice Chairman of Cell Therapy Institute, were invited to attend the meeting. At the meeting, Prof. Law presented the capabilities of human myoblasts in self-renewal and in promoting muscle fiber regeneration without the risk of tumors and unwanted cell differentiation. He expressed that myoblast transplantation technology has clinical therapeutic value in the treating muscle atrophy, heart disease, diabetes, solid carcinoma and other ailments. Prof. Law was willing to contribute his technology and experience to Chinese and Henan patients. In addition, the hospital leadership exchanged ideas with Prof. Law on the program for clinical myoblast treatment. They had an amicable and in-depth discussion on collaborating with each other.